TGFB1 and triple-negative breast carcinoma: For example, asporin binds directly to extracellular TGF-β1 in triple-negative breast cancer and its downstream cytoplasmatic component Smad 2/3 in colorectal cancer, resulting in inhibition or activation of the TGF-β1 signaling pathway, respectively (11, 12).